Medtronic Competitors

MDT Stock

USD 80.23 0.10 0.12%

Medtronic PLC competes with Ensign, Select Medical, Encompass Health, Enhabit, and Pennant; as well as few others. The company runs under Health Care Equipment & Supplies sector within Health Care industry. Analyzing Medtronic PLC competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Medtronic PLC to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Medtronic PLC Correlation with its peers.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Medtronic PLC competition on your existing holdings.

Return On Tangible Assets is likely to gain to 0.18 in 2024, whereas Return On Capital Employed is likely to drop 0.05 in 2024. At this time, Medtronic PLC's Intangibles To Total Assets are comparatively stable compared to the past year.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medtronic PLC's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.

Hype

Prediction

Low	Estimated	High
79.19	80.27	81.35

Details

Intrinsic

Valuation

Low	Real	High
72.21	86.22	87.30

Details

Naive

Forecast

Low	Next	High
77.51	78.59	79.68

Details

33 Analysts

Consensus

Low	Target	High
82.30	90.44	100.39

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Medtronic PLC. Your research has to be compared to or analyzed against Medtronic PLC's peers to derive any actionable benefits. When done correctly, Medtronic PLC's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Medtronic PLC.

Medtronic PLC Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Medtronic PLC and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Medtronic and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Medtronic PLC does not affect the price movement of the other competitor.

	ENSG	SEM	EHC	EHAB	PNTG	NHC	CCEL
ENSG		0.61	0.52	-0.13	0.63	0.06	0.18	ENSG
SEM	0.61		0.88	0.49	0.93	-0.32	0.75	SEM
EHC	0.52	0.88		0.33	0.89	-0.42	0.78	EHC
EHAB	-0.13	0.49	0.33		0.41	-0.19	0.6	EHAB
PNTG	0.63	0.93	0.89	0.41		-0.33	0.74	PNTG
NHC	0.06	-0.32	-0.42	-0.19	-0.33		-0.55	NHC
CCEL	0.18	0.75	0.78	0.6	0.74	-0.55		CCEL
	ENSG	SEM	EHC	EHAB	PNTG	NHC	CCEL

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

High positive correlations

PNTG	+ 0.93	SEM
PNTG	+ 0.89	EHC
EHC	+ 0.88	SEM
CCEL	+ 0.78	EHC
CCEL	+ 0.75	SEM
CCEL	+ 0.74	PNTG

High negative correlations

CCEL	- 0.55	NHC
NHC	- 0.42	EHC
NHC	- 0.33	PNTG
NHC	- 0.32	SEM
NHC	- 0.19	EHAB
EHAB	- 0.13	ENSG

Risk-Adjusted Indicators

There is a big difference between Medtronic Stock performing well and Medtronic PLC Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Medtronic PLC's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
ENSG	0.98	0.00	0.00	0.07	1.13	(1.12)	2.38	(2.33)	7.13
SEM	1.32	0.02	0.03	0.08	1.39	(1.44)	2.43	(2.34)	12.75
EHC	0.99	0.19	0.20	0.28	0.70	(1.21)	2.76	(1.43)	7.95
EHAB	2.51	(0.14)	(0.01)	0.02	2.97	(2.73)	5.48	(4.79)	27.98
PNTG	1.77	0.34	0.22	0.28	1.49	(2.22)	3.45	(3.21)	13.54
NHC	1.25	(0.16)	0.00	(0.07)	0.00	0.00	2.18	(2.67)	7.84
CCEL	3.07	0.39	0.10	0.76	2.91	(3.69)	7.79	(6.04)	23.27

Cross Equities Net Income Analysis

Compare Medtronic PLC and related stocks such as Ensign Group, Select Medical Holdings, and Encompass Health Corp Net Income Over Time

Select Fundamental

	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
ENSG	3.6 M	47.7 M	40.6 M	24 M	36 M	55.4 M	50 M	40.5 M	92.4 M	110.5 M	170.5 M	194.7 M	224.7 M	209.4 M	219.9 M
SEM	(27.9 M)	107.8 M	148.2 M	114.4 M	120.6 M	130.7 M	115.4 M	177.2 M	137.8 M	201 M	259 M	402.2 M	159 M	243.5 M	150.2 M
EHC	(1.5 M)	208.7 M	185 M	323.6 M	222 M	183.1 M	247.6 M	256.3 M	292.3 M	358.7 M	284.2 M	412.2 M	271 M	352 M	369.6 M
EHAB	24 M	24 M	24 M	24 M	24 M	24 M	24 M	24 M	24 M	24 M	75 M	111.1 M	62.5 M	(80.5 M)	(76.5 M)
PNTG	7.9 M	7.9 M	7.9 M	7.9 M	7.9 M	7.9 M	7.9 M	9.9 M	15.7 M	2.5 M	15.7 M	2.1 M	6.6 M	13.4 M	7.4 M
NHC	17.7 M	64.1 M	58 M	64.6 M	53.4 M	53.1 M	50.5 M	56.2 M	59 M	68.2 M	41.9 M	138.6 M	22.4 M	66.8 M	43 M
CCEL	600 K	(6.3 M)	27.4 K	553.6 K	8.1 M	(1.3 M)	2.3 M	(854.8 K)	2.3 M	3.6 M	2.1 M	2.8 M	(9.5 M)	(10.9 M)	(10.4 M)

Medtronic PLC and related stocks such as Ensign Group, Select Medical Holdings, and Encompass Health Corp Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Medtronic PLC financial statement analysis. It represents the amount of money remaining after all of Medtronic PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Medtronic PLC Competitive Analysis

The better you understand Medtronic PLC competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Medtronic PLC's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Medtronic PLC's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	MDT	ENSG	SEM	EHC	EHAB	PNTG	NHC	CCEL
	0.12 80.23 Medtronic	0.49 118.69 Ensign	1.67 27.59 Select	0.30 80.73 Encompass	0.29 10.43 Enhabit	1.44 19.91 Pennant	1.31 87.97 National	1.80 7.08 CryoCell
Market Volatility (90 Days Market Risk)	Very steady	Very steady	Very steady	Very steady	Somewhat reliable	Not too volatile	Very steady	Slightly risky
Market Performance (90 Days Performance)	Very Weak	Weak	Modest	Good	Weak	Good	Very Weak	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Very Low	Very Low	Low	Low	Above Average	Low	Very Low	Low
Current Valuation (Equity Enterprise Value)	Under Valued	Fairly Valued	Under Valued	Under Valued	Over Valued	Over Valued	Over Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Buy	Buy	Strong Buy	Strong Buy	Hold	Strong Buy	Strong Sell	Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Hold	Hold	Hold	Buy	Strong Sell	Buy	Strong Hold	Cautious Hold
Current Ratio	1.76 X	1.28 X	1.02 X	1.21 X	1.41 X	1.00 X	1.76 X	0.47 X
Net Asset	90.95 B	4.18 B	7.69 B	6.1 B	1.47 B	539.69 M	1.31 B	61.22 M
Profit Margin	0.13 %	0.06 %	0.04 %	0.07 %	(0.08) %	0.02 %	0.06 %	(0.30) %
EBITDA	9.04 B	353.24 M	804.43 M	1.01 B	69.1 M	30.71 M	87.99 M	5.2 M
Operating Margin	0.19 %	0.02 %	0.07 %	0.15 %	0.02 %	0.05 %	0.05 %	(0.51) %
Current Valuation	123.46 B	8.05 B	8.42 B	11.57 B	1.14 B	930.13 M	1.24 B	69.66 M
Price To Book	2.05 X	4.55 X	2.80 X	4.89 X	0.78 X	4.32 X	1.51 X	9.72 X
Retained Earnings	30.39 B	1.14 B	751.86 M	406.5 M	254.5 M	34.66 M	687.6 M	(31.16 M)
Current Asset	23.6 B	279.57 M	749.15 M	659.58 M	N/A	N/A	164.61 M	6.08 M
Five Year Return	2.18 %	0.39 %	N/A	1.65 %	N/A	N/A	2.89 %	N/A
Beta	0.78	0.94	1.38	0.83	N/A	2.06	0.38	0.55
Number Of Employees	95 K	35.3 K	38.4 K	22.36 K	10.8 K	5.79 K	13.12 K	82
Shares Outstanding	1.33 B	56.9 M	128.36 M	100.14 M	50.16 M	30.01 M	15.4 M	8.29 M
Cash Flow From Operations	6.04 B	376.67 M	582.06 M	850.8 M	45.2 M	33.09 M	111.22 M	8.92 M
Annual Yield	0.03 %	0 %	0.02 %	0.01 %	N/A	N/A	0.03 %	N/A
Total Debt	24.36 B	1.87 B	4.96 B	2.93 B	610.1 M	329.63 M	93.39 M	10.9 M
Return On Equity	0.0817	0.15	0.2	0.23	-0.11	0.1	0.073	1.29
Return On Asset	0.0423	0.0418	0.0452	0.0779	0.0161	0.03	0.0248	-0.0025
Number Of Shares Shorted	12.43 M	3.27 M	2.22 M	2.47 M	3.53 M	322.68 K	520.11 K	9.45 K
Book Value Per Share	38.95 X	26.57 X	10.04 X	16.43 X	13.38 X	4.63 X	59.20 X	(1.33) X
Current Liabilities	7.17 B	179.87 M	729.28 M	474.74 M	N/A	N/A	114.08 M	2.82 M
Total Asset	90.95 B	4.18 B	7.69 B	6.1 B	1.47 B	539.69 M	1.31 B	61.22 M
Debt To Equity	0.51 %	1.25 %	3.68 %	1.69 %	0.72 %	2.66 %	0.17 %	0.26 %
Short Ratio	1.96 X	12.65 X	4.82 X	3.66 X	3.92 X	2.25 X	6.79 X	1.22 X
Target Price	94.18	133.25	35.8	88.3	10.93	21.75	6.15	8.0
Last Dividend Paid	2.75	0.23	0.5	0.6	N/A	N/A	2.34	N/A
Shares Owned By Institutions	85.18 %	98.10 %	78.44 %	98.58 %	97.70 %	86.91 %	57.80 %	10.56 %
Market Capitalization	106.4 B	6.79 B	3.6 B	8.06 B	521.62 M	606.25 M	1.37 B	59.75 M
Price To Earning	20.44 X	29.50 X	13.33 X	18.73 X	6.49 X	34.12 X	22.85 X	10.76 X
Price To Earnings To Growth	1.52 X	1.48 X	1.37 X	1.37 X	(1.70) X	1.82 X	N/A	N/A
Price To Sales	3.29 X	1.82 X	0.54 X	1.68 X	0.50 X	1.11 X	1.21 X	1.91 X
Net Income	3.78 B	209.85 M	299.73 M	361.6 M	(80.5 M)	13.91 M	66.8 M	(9.52 M)
Earnings Per Share	3.15 X	3.65 X	1.91 X	3.59 X	(1.61) X	0.44 X	4.34 X	(1.14) X
Shares Owned By Insiders	0.10 %	3.48 %	17.27 %	1.42 %	2.30 %	8.64 %	19.59 %	46.17 %
Revenue	31.23 B	3.73 B	6.66 B	4.8 B	1.05 B	544.89 M	1.12 B	31.34 M
Working Capital	12.62 B	312.18 M	9.18 M	185.4 M	72.4 M	8.53 M	191.76 M	(11.41 M)
Cash And Equivalents	1.54 B	321.1 M	97.91 M	21.8 M	50.2 M	3.2 M	58.67 M	2.96 M
Cash Per Share	8.59 X	5.79 X	1.35 X	0.60 X	1.01 X	0.11 X	14.19 X	0.35 X
Gross Profit	21.71 B	534.92 M	1.1 B	1.75 B	545.5 M	103.15 M	388.11 M	21.54 M
Day Typical Price	80.53	118.69	27.79	80.9	10.36	20.12	88.51	6.96
Accumulation Distribution	0.0273	2842.4	33303.81	10543.54	13602.29	3480.05	577.23	788.73
Market Facilitation Index	2.23	0.0	0.0	0.0	0.0	0.0	1.0E-4	1.0E-4
Daily Balance Of Power	0.0448	(0.35)	(0.39)	0.1569	0.0968	(0.44)	(0.72)	(0.18)
Period Momentum Indicator	0.1	(0.59)	(0.47)	0.24	0.03	(0.29)	(1.17)	(0.13)
Rate Of Daily Change	1.0	1.0	0.98	1.0	1.0	0.99	0.99	0.98
Day Median Price	80.68	118.69	27.89	80.99	10.33	20.22	88.79	6.9
Price Action Indicator	(0.39)	(0.30)	(0.53)	(0.13)	0.12	(0.46)	(1.40)	0.12
Coefficient Of Variation	(1,064)	1802.94	1494.75	525.12	6906.82	508.26	(2,252)	975.17
Mean Deviation	0.7872	0.9835	1.32	0.9947	2.51	1.77	1.25	3.07
Jensen Alpha	(0.18)	0.0018	0.0202	0.1902	(0.14)	0.3389	(0.16)	0.3862
Total Risk Alpha	(0.23)	(0.08)	(0.09)	0.1005	(0.39)	0.1907	(0.25)	(0.04)
Sortino Ratio	N/A	(0)	0.032	0.196	(0.01)	0.2171	N/A	0.103
Downside Variance	N/A	1.44	2.26	0.8802	9.41	3.02	N/A	11.96
Standard Deviation	1.07	1.35	1.89	1.38	3.98	2.32	1.55	4.24
Kurtosis	2.04	1.6	9.57	5.56	13.82	4.06	0.2672	2.36
Potential Upside	1.27	2.38	2.43	2.76	5.48	3.45	2.18	7.79
Treynor Ratio	(0.11)	0.0702	0.0825	0.2778	0.0173	0.2846	(0.07)	0.7573
Maximum Drawdown	5.94	7.13	12.75	7.95	27.98	13.54	7.84	23.27
Variance	1.14	1.81	3.57	1.89	15.88	5.37	2.39	17.94
Market Risk Adjusted Performance	(0.10)	0.0802	0.0925	0.2878	0.0273	0.2946	(0.06)	0.7673
Risk Adjusted Performance	(0.05)	0.0398	0.0482	0.1234	0.0174	0.1292	(0.02)	0.072
Skewness	0.3528	0.5739	2.02	1.67	2.64	1.1	0.085	1.1
Semi Deviation	N/A	1.13	1.39	0.6986	2.97	1.49	N/A	2.91
Information Ratio	(0.17)	(0)	0.0255	0.1336	(0.01)	0.163	(0.09)	0.0841
Value At Risk	(1.95)	(2.33)	(2.34)	(1.43)	(4.79)	(3.21)	(2.67)	(6.04)
Expected Short fall	N/A	(1.12)	(1.44)	(1.21)	(2.73)	(2.22)	N/A	(3.69)
Downside Deviation	N/A	1.2	1.5	0.9382	3.07	1.74	N/A	3.46
Semi Variance	N/A	1.28	1.93	0.4881	8.8	2.22	N/A	8.46

Medtronic PLC Competition Performance Charts

Five steps to successful analysis of Medtronic PLC Competition

Medtronic PLC's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Medtronic PLC in relation to its competition. Medtronic PLC's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of Medtronic PLC in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Medtronic PLC's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Medtronic PLC, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Medtronic PLC position

In addition to having Medtronic PLC in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate

Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Real Estate theme has 61 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.

View All Next

Launch

When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:

How To Invest In Medtronic

Details

Is Medtronic Stock a good investment?

Details

What is Medtronic PLC's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Medtronic PLC Correlation with its peers.

For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Note that the Medtronic PLC information on this page should be used as a complementary analysis to other Medtronic PLC's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Medtronic Stock analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.

	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators

Is Medtronic PLC's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medtronic PLC. If investors know Medtronic will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medtronic PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.078

Dividend Share

2.75

Earnings Share

3.15

Revenue Per Share

24.298

Quarterly Revenue Growth

0.047

The market value of Medtronic PLC is measured differently than its book value, which is the value of Medtronic that is recorded on the company's balance sheet. Investors also form their own opinion of Medtronic PLC's value that differs from its market value or its book value, called intrinsic value, which is Medtronic PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medtronic PLC's market value can be influenced by many factors that don't directly affect Medtronic PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Medtronic PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medtronic PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medtronic PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Medtronic Competitors

Specify up to 10 symbols:

Medtronic PLC Competition Correlation Matrix

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Medtronic PLC and related stocks such as Ensign Group, Select Medical Holdings, and Encompass Health Corp Net Income description

Medtronic PLC Competitive Analysis

Medtronic PLC Competition Performance Charts

Five steps to successful analysis of Medtronic PLC Competition

Complement your Medtronic PLC position

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate

Complementary Tools for Medtronic Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY